Business Context and Reporting Period
This Form 8-K Current Report was filed by AEye, Inc. on January 17, 2022. The report details corporate governance changes, specifically the appointment of a new director and the expansion of the Board of Directors. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Dublin, California.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel appointments and associated compensation arrangements.
Material Changes
- Board Expansion: The Board of Directors increased its size from seven to eight members effective January 17, 2022.
- New Director Appointment: Sue Zeifman was appointed as a Class I director, effective immediately, with a term expiring at the 2022 annual meeting of stockholders.
- Committee Assignment: Ms. Zeifman was appointed to the newly established Marketing Committee of the Board.
Compensation and Management Commentary
The filing outlines the compensatory arrangements for the new director, Sue Zeifman:
- Annual Cash Compensation: $50,000 per year, paid in quarterly installments.
- Initial Equity Grant: A one-time grant of Restricted Stock Units (RSUs) with a market value of $350,000, vesting over a three-year period. The number of RSUs was calculated based on the average closing price of the Company's common stock over the five trading days preceding the appointment.
- Committee Compensation: As a member of the Marketing Committee, Ms. Zeifman will receive $25,000 and 2,500 RSUs per calendar quarter.
- Indemnification: The Company will enter into its standard form of indemnification agreement with Ms. Zeifman.
On January 18, 2022, the Company issued a press release announcing this appointment, which is furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the exact number of RSUs granted to Ms. Zeifman by reviewing the stock price data for the five trading days preceding January 17, 2022.
- Confirm the total dilution impact of the new director grants and committee compensation on existing shareholders.
- Review the press release (Exhibit 99.1) for additional context on the strategic rationale for establishing the Marketing Committee.
- Check subsequent filings for the formal ratification of Ms. Zeifman's appointment at the 2022 annual meeting of stockholders.